This four-amino acid sequence (Ala-Glu-Asp-Gly) was first developed by Russian scientist Professor Vladimir Khavinson in the 1980s
Given that LA is a necessary cofactor for mitochondrial -ketoacid dehydrogenases, it thus serves a critical role in mitochondrial energy metabolism
ANGPTL3 decreases very low-density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase
Technical Characteristics Compound name: 5-Amino-1MQ Type: Synthetic compound (non-peptidic) Form: Powder Purity: 98% Regulatory status: Research Use Only (RUO) Classification: Not intended for clinical, therapeutic, or diagnostic use Each batch is tested to ensure identity, purity, and consistency, ensuring reliability for scientific research applications
Sachan et al., 1984), promotes the clearance of fatty acid ethyl esters (Calabrese and Rizza, 1999